JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerkhoff, F. T.
Right arrow Articles by Rothova, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerkhoff, F. T.
Right arrow Articles by Rothova, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 1999, p. 4034-4038, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Demonstration of Bartonella grahamii DNA in Ocular Fluids of a Patient with Neuroretinitis

F. T. Kerkhoff,1,* A. M. C. Bergmans,2 A. van der Zee,2 and A. Rothova1

Department of Ophthalmology, F. C. Donders Institute, University Hospital, Utrecht,1 and Laboratory of Molecular Microbiology, St. Elisabeth Hospital, Tilburg,2 The Netherlands

Received 26 April 1999/Returned for modification 4 June 1999/Accepted 24 August 1999

We describe the clinical and laboratory features of a 55-year-old human immunodeficiency virus-negative female patient who presented with bilateral intraocular inflammatory disease (neuroretinitis type) and behavioral changes caused by a Bartonella grahamii infection. Diagnosis was based on the PCR analysis of DNA extracted from the intraocular fluids. DNA analysis of the PCR product revealed a 100% identity with the 16S rRNA gene sequence of B. grahamii. The patient was successfully treated with doxycycline (200 mg/day) and rifampin (600 mg/day) for 4 weeks. This is the first report that demonstrates the presence of a Bartonella species in the intraocular fluids of a nonimmunocompromised patient and that indicates that B. grahamii is pathogenic for humans.

* Corresponding author. Mailing address: Department of Ophthalmology, F. C. Donders Institute, Academic Hospital Utrecht, P.O. Box 85 500, 3508 GA Utrecht, The Netherlands. Phone: (30) 2507880. Fax: (30) 250 54 17. E-mail: fkerkh{at}oogheel.azu.nl.

Journal of Clinical Microbiology, December 1999, p. 4034-4038, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1999 by the American Society for Microbiology. All rights reserved.